TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia

被引:130
作者
Sabaawy, Hatem E. [1 ]
Azuma, Mizuki
Embree, Lisa J.
Tsai, Huai-Jen
Starost, Matthew F.
Hickstein, Dennis D.
机构
[1] NCI, Expt Transplantat & Immunol Branch, Canc Res Ctr, Bethesda, MD 20892 USA
[2] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10617, Taiwan
[3] NIH, Div Vet Resources, Off Res Serv, Bethesda, MD 20892 USA
关键词
stem cell; translocation; childhood cancer; genetics;
D O I
10.1073/pnas.0603349103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Acute lymphoblastic leukemia (ALL) is a clonal disease that evolves through the accrual of genetic rearrangements and/or mutations within the dominant clone. The TEL-AML1 (ETV6-RUNX1) fusion in precursor-B (pre-B) ALL is the most common genetic rearrangement in childhood cancer; however, the cellular origin and the molecular pathogenesis of TEL-AML1-induced leukemia have not been identified. To study the origin of TEL-AML1-induced ALL, we generated transgenic zebrafish expressing TEL-AML1 either ubiquitously or in lymphoid progenitors. TEL-AML1 expression in all lineages, but not lymphoid-restricted expression, led to progenitor cell expansion that evolved into oligoclonal B-lineage ALL in 3% of the transgenic zebrafish. This leukemia was transplantable to conditioned wildtype recipients. We demonstrate that TEL-AML1 induces a B cell differentiation arrest, and that leukemia development is associated with loss of TEL expression and elevated Bcl2/Bax ratio. The TEL-AML1 transgenic zebrafish models human pre-B ALL, identifies the molecular pathways associated with leukemia development, and serves as the foundation for subsequent genetic screens to identify modifiers and leukemia therapeutic targets.
引用
收藏
页码:15166 / 15171
页数:6
相关论文
共 48 条
[1]   The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo [J].
Andreasson, P ;
Schwaller, J ;
Anastasiadou, E ;
Aster, J ;
Gilliland, DG .
CANCER GENETICS AND CYTOGENETICS, 2001, 130 (02) :93-104
[2]   Myelopoiesis in the zebrafish, Danio rerio [J].
Bennett, CM ;
Kanki, JP ;
Rhodes, J ;
Liu, TX ;
Paw, BH ;
Kieran, MW ;
Langenau, DM ;
Delahaye-Brown, A ;
Zon, LI ;
Fleming, MD ;
Look, AT .
BLOOD, 2001, 98 (03) :643-651
[3]  
Bernardin F, 2002, CANCER RES, V62, P3904
[4]   Isolation and characterization of runxa and runxb, zebrafish members of the runt family of transcriptional regulators [J].
Burns, CE ;
DeBlasio, T ;
Zhou, Y ;
Zhang, J ;
Zon, L ;
Nimer, SD .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (12) :1381-1389
[5]   Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model [J].
Fischer, M ;
Schwieger, M ;
Horn, S ;
Niebuhr, B ;
Ford, A ;
Roscher, S ;
Bergholz, U ;
Greaves, M ;
Löhler, J ;
Stocking, C .
ONCOGENE, 2005, 24 (51) :7579-7591
[6]   One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus [J].
Gilley, J ;
Fried, M .
ONCOGENE, 2001, 20 (50) :7447-7452
[7]   FUSION OF THE TEL GENE ON 12P13 TO THE AML1 GENE ON 21Q22 IN ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
GOLUB, TR ;
BARKER, GF ;
BOHLANDER, SK ;
HIEBERT, SW ;
WARD, DC ;
BRAYWARD, P ;
MORGAN, E ;
RAIMONDI, SC ;
ROWLEY, JD ;
GILLILAND, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4917-4921
[8]   A matter of life and death [J].
Green, DR ;
Evan, GI .
CANCER CELL, 2002, 1 (01) :19-30
[9]   TEL/AML1 shows dominant-negative effects over TEL as well as AML1 [J].
Gunji, H ;
Waga, K ;
Nakamura, F ;
Maki, K ;
Sasaki, K ;
Nakamura, Y ;
Mitani, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 322 (02) :623-630
[10]   RESOLUTION AND CHARACTERIZATION OF PRO-B AND PRE-PRO-B CELL STAGES IN NORMAL MOUSE BONE-MARROW [J].
HARDY, RR ;
CARMACK, CE ;
SHINTON, SA ;
KEMP, JD ;
HAYAKAWA, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) :1213-1225